Sector: Health Care
Director information for MODERNA INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Abbas Hussain | Director | 61 | ["Former CEO, Vifor Pharma","Former Global President, Pharmaceuticals and Vaccines, GSK","More than three decades of leadership and operating experience in the healthcare industry","Deep experience in the commercialization of pharmaceutical products","CEO of Vifor Pharmaceuticals from 2021 to 2023","Global President, Pharmaceuticals and Vaccines at GlaxoSmithKline from 2008 to 2017","Various leadership roles at Eli Lilly and Company for 20 years"] | [] | 2026 |
| David Berman, M.D., Ph.D. | Chief Development Officer | 55 | ["S.B. in Biology from Massachusetts Institute of Technology","M.D., Ph.D. from University of Texas Southwestern Medical School","Oversaw Moderna’s development strategy","Responsible for Moderna’s development organization","Worked at Immunocore as Executive Vice President and Head of Research and Development","Completed an anatomic pathology residency at the National Cancer Institute","Completed a fellowship at the Johns Hopkins Hospital"] | [] | 2026 |
| David Rubenstein | Director; Co-Founder and Co-Chairman | 76 | ["Co-Founder and Co-Chair, The Carlyle Group","Decades of experience in growing and investing in global companies","Insight on geopolitical trends, policy and international affairs","Experience as a founder, CEO, and public company director","Experience in financial reporting and governance","Former Deputy Assistant to the President for Domestic Policy","Former Chief Counsel to the U.S. Senate Judiciary Committee’s Subcommittee on Constitutional Amendments"] | [] | 2026 |
| Dr. Nader | CEO and Executive Director | ["Decades of experience in the healthcare industry","Former CEO of NPS Pharmaceuticals","Experience on the boards of public and private healthcare companies","Former Chairman of BioNJ","Served on Aventis Pharma’s North America Leadership Team","Senior advisor for Blackstone Life Sciences"] | ["Tectonic Therapeutic, Inc.","BenevolentAI","Talaris Therapeutics, Inc.","Acceleron Pharma Inc.","Alexion Pharmaceuticals, Inc.","Prevail Therapeutics Inc."] | 2026 | |
| Elizabeth Nabel, M.D. | Director | 74 | ["Former President, Brigham Health"] | [] | 2026 |
| Elizabeth Tallett | Director | 76 | ["Former Principal, Hunter Partners","Extensive professional experience in the pharmaceutical industry","Executive for organizations at various stages of development","Public company director with service on numerous public company boards across multiple industries","Chair or lead independent director for several public companies","Governance expertise in financial reporting, human capital management, and risk management","Experience in strategic leadership and operational roles in biopharmaceutical and consumer products","Former President and CEO of Transcell Technologies Inc.","Former President of Centocor Pharmaceuticals","Consultant with early-stage healthcare companies"] | [] | 2026 |
| François Nader, M.D. | Director | 69 | ["Former President, CEO and Executive Director, NPS Pharmaceuticals"] | [] | 2026 |
| Jerh Collins | Chief Technical Operations and Quality Officer | 60 | ["Bachelor of Science in Chemistry","Ph.D. in Organic Chemistry","Oversaw technical development, quality, and supply at Moderna","Nearly 30 years at Novartis with roles in pharmaceutical production and manufacturing","Chief Culture Officer at Novartis"] | [] | 2026 |
| Noubar Afeyan, Ph.D. | Chairman | 63 | ["CEO, Flagship Pioneering","Co-founder and Chairman, Moderna"] | [] | 2026 |
| Sandra Horning, M.D. | Director | 77 | ["Former Chief Medical Officer and Global Head of Product Development, Roche"] | [] | 2026 |
| Stéphane Bancel | CEO; Chief Executive Officer | 53 | ["CEO of Moderna since October 2011","Former CEO of bioMérieux SA","Experience at Eli Lilly and Company","Venture Partner at Flagship Pioneering","Nominated Chevalier of the Legion d'honneur in 2022","Elected to the U.S. National Academy of Engineering in 2024","Master of Engineering from École Centrale Paris","Master of Science in Chemical Engineering from University of Minnesota","M.B.A. from Harvard Business School","Former Managing Director at Eli Lilly and Company","Experience in Asia-Pacific Sales and Marketing at bioMérieux"] | [] | 2026 |
| Stephen Hoge, M.D. | President | 50 | ["B.A. in Neuroscience from Amherst College","M.D. from University of California, San Francisco","Oversaw Moderna’s commercial organization","Responsible for strategy across research & development, medical affairs and commercial functions","Employed by McKinsey & Company from 2005 to 2012 as a Partner and leader in healthcare practice","Resident physician at New York University/Bellevue Hospital from 2004 to 2005"] | [] | 2026 |
